Gian Life Care
Ticker >

Gian Life Care share price

Gian Life Care Ltd.

BSE: 542918 SECTOR: Hospital & Healthcare Services  11k   58   2

20.73
-0.07 (-0.34%)
BSE: 23 Apr 03:41 PM

Price Summary

Today's High

₹ 21.58

Today's Low

₹ 20.21

52 Week High

₹ 29

52 Week Low

₹ 18.16

FinStar is Suspended!

FinStar can not be assigned to this company due to its dicey outlook and insufficient data. We will update the FinStar for this company as soon as the data is updated from its end.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 21.44 Cr.

Enterprise Value

₹ 18.73 Cr.

No. of Shares

1.03 Cr.

P/E

17.91

P/B

1.23

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  16.84

CASH

₹ 4.74 Cr.

DEBT

₹ 2.03 Cr.

Promoter Holding

48.47 %

EPS (TTM)

₹  1.16

Sales Growth

52.36%

ROE

36.94 %

ROCE

53.19%

Profit Growth

116.86 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year52.36%
3 Year205.57%
5 YearNA

Profit Growth

1 Year116.86%
3 Year251.89%
5 YearNA

ROE%

1 Year36.94%
3 Year29.78%

ROCE %

1 Year53.19%
3 Year43.86%

Debt/Equity

0.1446

Price to Cash Flow

3.7

Interest Cover Ratio

5.67164179104477

CFO/PAT (5 Yr. Avg.)

0

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2024 48.47 26.53
Dec 2023 51.73 0
Sep 2023 53.1 0
Jun 2023 53.1 0
Mar 2023 56.9 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 251.885640868539% for the Past 3 years.
  • The company has shown a good revenue growth of 205.568422319556% for the Past 3 years.
  • Company has been maintaining healthy ROE of 29.7832812186617% over the past 3 years.
  • Company has been maintaining healthy ROCE of 43.8564097665856% over the past 3 years.
  • The company has an efficient Cash Conversion Cycle of -133.102017532728 days.

 Limitations

  • Promoter pledging has increased from 0% to 26.53% in 1 quarter.
  • The company has a low EBITDA margin of 0% over the past 5 years.
  • Promoter pledging is high as 26.53%.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 5.09 1.55 2.43 2.3 3.79
Total Expenditure 2.8 2.27 1.92 1.97 1.55
Operating Profit 2.29 -0.72 0.51 0.33 2.24
Other Income 0.17 0.18 0.15 0.15 0.16
Interest 0.12 0.11 0.12 0.11 0.11
Depreciation 0.14 0.12 0.13 0.13 0.13
Exceptional Items 0 0 0 0 0
Profit Before Tax 2.2 -0.77 0.41 0.24 2.16
Tax 0.31 0.13 0.14 0.04 0.53
Profit After Tax 1.89 -0.9 0.27 0.21 1.63
Adjusted EPS (Rs) 1.83 -0.87 0.26 0.2 1.57

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022
Net Sales 0.56 7.65 10.46 15.93
Total Expenditure 0.36 5.33 6.98 9
Operating Profit 0.2 2.32 3.48 6.93
Other Income 0 0.1 0.29 0.51
Interest 0.04 0.61 0.73 1.25
Depreciation 0.02 0.26 0.29 0.33
Exceptional Items 0 0 0 0
Profit Before Tax 0.14 1.56 2.75 5.85
Tax 0.04 0.43 0.74 1.48
Net Profit 0.1 1.13 2.02 4.37
Adjusted EPS (Rs.) 0.23 1.09 1.95 4.23

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022
Equity and Liabilities
Share Capital 0.01 4.7 4.7 10.34
Total Reserves 0.1 2.94 4.96 3.69
Borrowings 0.98 0.75 0.62 1.87
Other N/C liabilities 0 0.17 0.17 0.26
Current liabilities 6.72 3.81 5.03 6.9
Total Liabilities 7.82 12.37 15.48 23.06
Assets
Net Block 2.91 2.84 2.99 3.5
Capital WIP 0 0 0 0.12
Intangible WIP 0 0 0 0
Investments 0 0 0 0.11
Loans & Advances 1.49 5.44 6.46 8.73
Other N/C Assets 0 0 0 0.29
Current Assets 3.41 4.09 6.03 10.31
Total Assets 7.82 12.37 15.48 23.06
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022
Profit from operations 0.14 1.56 2.75 5.85
Adjustment 0.04 0.6 0.42 1.93
Changes in Assets & Liabilities 2.81 -0.42 -0.01 -1.32
Tax Paid 0 -0.23 -0.3 -0.67
Operating Cash Flow 2.99 1.51 2.87 5.79
Investing Cash Flow -2.92 -3.96 -1.1 -4.23
Financing Cash Flow 0.96 2.55 -0.39 0.67
Net Cash Flow 1.03 0.1 1.38 2.23

Corporate Actions

Investors Details

PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
promoters 56.90 53.10 53.10 51.73 48.47
arun kumar gupta 53.81 50.01 50.01 48.64 45.37
avani gupta 2.24 2.24 2.24 2.24 2.24
devang agarwal 0.42 0.42 0.42 0.42 0.42
rashika agarwal 0.42 0.42 0.42 0.42 0.42
PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
investors 43.10 46.90 46.90 48.27 51.53
nathabhai bhikhabhai pate... - - - - 1.07
prashant prithviraj jain - 1.00 1.02 1.07 1.11
rajesh mahohar makode - - - - 1.06
shield multistate coopera... - 2.55 4.59 4.59 7.14
digonta bordoloi 2.07 2.11 1.88 1.89 -
sushil madhukar chavan - 1.55 - - -

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

  • PresentationQ2FY22 22 Nov 2021

Gian Life Care Stock Price Analysis and Quick Research Report. Is Gian Life Care an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Gian Life Care and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Gian Life Care cash from the operating activity was Rs 5.7926 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Gian Life Care has a Debt to Equity ratio of 0.1446 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Gian Life Care , the EPS growth was 116.86147851943 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Gian Life Care has OPM of 43.4917167303841 % which is a good sign for profitability.
     
  • ROE: Gian Life Care have a healthy ROE of 36.937807931167 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Gian Life Care is Rs 20.73. One can use valuation calculators of ticker to know if Gian Life Care share price is undervalued or overvalued.
Last Updated on:
Brief about Gian Life Care
X